Effect of Modifying Anti-platelet Treatment to Ticagrelor in Patients With Diabetes and Low Response to Clopidogrel
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 500 participants.
Also called NCT01643031
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 500 participants
- Registry
-
NCT01643031
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Israel
- Registry status
- Unknown status
Technical summary
Registry record NCT01643031. Randomized; no masking; primary purpose treatment. Start 2012-08 (registry gives no type); primary completion 2014-09 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effect of Modifying Anti-platelet Treatment to Ticagrelor in Patients With Diabetes and Low Response to Clopidogrel
- Acronym
- MATTIS-D
- Condition
- Diabetes Mellitus
- Condition
- Coronary Disease
- Intervention (Drug)
- Ticagrelor
- Intervention (Drug)
- Continued clopidogrel
- Lead sponsor
- Rabin Medical Center
- Collaborator
- Tel Aviv Medical Center
- Collaborator
- Sheba Medical Center
- Collaborator
- Meir Medical Center
- Collaborator
- Rambam Health Care Campus
Record details
- Record id
cardio:ct-nct01643031- Content hash
7c5bb03b4f27603c40117dfcc51f4ea9b6c88786fa6d9d5acf32dd54ebf3bdab